Investigation Overview
Jan. 25, 2013 (Shareholders Foundation) -- An investigation on behalf of current long term investors in shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) was announced concerning whether certain officers and directors of Anthera Pharmaceuticals Inc breached their fiduciary duties by paying certain top officials at Anthera Pharmaceuticals excessive compensation. The investigation by...
You must register (for free) or login to view the entire investigation.